BlackRock Health Sciences Trust

BME · NYSE · Financial Services / Asset Management

47.59USD-0.03 (-0.06%)

Price History

Full chart

Market Stats

Previous Close47.62

Open47.44

Day Range47.15 – 47.71

52-Week Range33.54 – 46.16

Volume43.08K

Market Cap581.46M

P/E (TTM)5.54

Forward P/E0.00

EPS8.12

Dividend Yield6.99%

Beta0.59

50-Day Avg44.36

200-Day Avg41.60

About

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Company Details

SectorFinancial Services
IndustryAsset Management
CEOMr. Charles Choon Sik Park
Employees0
Headquarters50 Hudson Yards, New York, NY, United States, 10001, USA
Websitehttps://www.blackrock.com/investing/products/24022

Leadership

Mr. Charles Choon Sik ParkChief Compliance Officer and Anti-Money Laundering Officer · b. 1967
Mr. Thomas P. Callan C.F.A.Portfolio Manager
Mr. Kyle G. McClements C.F.A.Portfolio Manager
Dr. Erin Xie Ph.D.Portfolio Manager · b. 1968

Financials

Income Statement

Currency: USD	2006-12-31	2007-12-31	2008-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	26.95M	39.02M	14.50M	2.97M	3.64M	3.19M	54.91M	25.82M	60.73M	22.89M	80.29M	80.09M	59.66M	-25.97M	34.90M	24.07M	36.16M
Growth (%)	-	+44.79%	-62.85%	-79.49%	+22.28%	-12.39%	+1623.74%	-52.97%	+135.19%	-62.31%	+250.80%	-0.25%	-25.51%	-143.53%	+234.36%	-31.02%	+50.21%
Cost of Revenue	2.24M	2.30M	2.38M	-	-	0	3.47M	3.00M	3.27M	3.69M	4.14M	4.95M	6.11M	5.94M	6.02M	78	5.63M
Gross Profit	24.72M	36.73M	12.11M	2.97M	3.64M	3.19M	51.44M	22.82M	60.73M	22.89M	80.29M	80.09M	59.66M	-25.97M	28.87M	24.07M	30.53M
Gross Margin	91.71%	94.12%	83.57%	100.00%	100.00%	100.00%	93.68%	88.37%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	82.75%	100.00%	84.44%
Operating Expense	137.38K	120.14K	28.72K	2.36M	2.71M	3.50M	18.12M	39.09M	392.04K	446.62K	413.57K	531.49K	541.46K	500.13K	20.41M	617.09K	-46.46M
Operating Income	24.58M	36.61M	12.09M	613.89K	923.73K	-313.54K	33.32M	-16.27M	60.34M	22.44M	79.88M	79.56M	59.12M	-26.47M	8.46M	23.45M	77.00M
Operating Margin	91.20%	93.81%	83.38%	20.65%	25.41%	-9.84%	60.68%	-63.03%	99.35%	98.05%	99.48%	99.34%	99.09%	101.93%	24.26%	97.44%	212.94%
EBITDA	-	-	-	31.53M	68.43M	50.66M	33.35M	-16.22M	60.34M	22.44M	79.88M	79.56M	59.12M	-26.47M	20.02M	23.45M	77.01M
EBITDA Margin	-	-	-	1060.49%	1882.09%	1590.49%	60.74%	-62.80%	99.35%	98.05%	99.48%	99.34%	99.09%	101.93%	57.38%	97.44%	212.99%
Net Income	24.58M	36.61M	-34.91M	32.14M	69.35M	50.35M	33.28M	-16.27M	60.34M	22.44M	79.88M	79.56M	59.12M	-26.47M	20.02M	23.45M	76.97M
Net Income Margin	91.20%	93.81%	-240.81%	1081.14%	1907.49%	1580.65%	60.60%	-63.00%	99.35%	98.05%	99.48%	99.34%	99.09%	101.93%	57.36%	97.44%	212.86%
R&D	-	-	-	-	-	-	0	0	0	0	-	-	-	-	-	-	-
R&D as % of Total Revenue	-	-	-	-	-	-	0.00%	0.00%	0.00%	0.00%	-	-	-	-	-	-	-
Interest Expense	0	0	0	-	-	0	0	0	0	0	0	0	0	-	55	78	45.69K
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	-	-	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%	0.13%

Balance Sheet

Currency: USD	2006-12-31	2007-12-31	2008-12-31	2010-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	216.04M	236.91M	187.82M	-	227.36M	273.97M	306.53M	300.96M	273.54M	334.61M	355.49M	1.73B	554.55M	648.81M	606.13M	596.10M	774.59M	570.14M
Total Liabilities	7.89M	6.63M	8.18M	-	8.99M	3.81M	3.42M	3.43M	2.85M	2.75M	2.81M	93.49M	8.62M	23.04M	5.93M	7.97M	6.03M	1.83M
Total Equity	208.15M	230.28M	179.64M	-	218.38M	270.16M	303.10M	297.53M	270.69M	331.86M	352.67M	1.64B	3.02B	625.77M	600.20M	588.14M	768.57M	568.30M
Cash	27.30K	51.69K	-	-	1.81K	2.50K	4.53K	1.21K	208.86K	959	288	501.31K	211.70K	960	3.12K	534	71.34K	548
Total Debt	-	-	-	-	-	-	-	-	126.90K	130.91K	4.67K	253.80K	102.70K	211.57K	2.92K	60.69K	299.17K	894.33K
Net Debt	-	-	-	-	-1.81K	-2.50K	-4.53K	-1.21K	-81.96K	10.01K	4.39K	-501.31K	-109.00K	-960	-3.12K	-534	-71.34K	893.78K

Cash Flow

Currency: USD	2006-12-31	2007-12-31	2008-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	24.58M	36.61M	-34.91M	16.44M	17.57M	115.30M	1.28M	2.01M	-1.17M	2.05M	-14.10M	-19.35M	-21.56M	-874.04K	32.02M	65.52M	-4.35M
Investing Cash Flow	-	-	-	-	-	-	0	0	0	0	-	-970.25K	-35.55K	-11.62M	34.78M	66.41M	37.30M
Financing Cash Flow	-14.43M	-14.48M	-15.73M	-16.44M	-17.57M	-115.33M	-39.78M	-9.86M	961.51K	-2.05M	14.23M	19.44M	21.34M	876.17K	-32.02M	-65.52M	-54.59M
Capital Expenditure	0	0	0	0	0	0	0	0	0	0	0	3	4	1	3	0	4
Free Cash Flow	-	-	-	16.44M	17.57M	115.30M	1.28M	2.01M	-1.17M	2.05M	-14.10M	-19.35M	-21.56M	-874.04K	32.02M	65.52M	-4.35M
Dividends Paid	14.43M	16.83M	15.73M	16.44M	17.57M	115.33M	49.22M	23.05M	19.96M	21.61M	23.25M	25.65M	29.00M	32.73M	35.10M	35.92M	40.61M
FCF to OCF	-	-	-	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Dividend Paid to FCF	-	-	-	100.01%	100.00%	100.02%	3847.49%	1147.44%	-1706.57%	1053.74%	-164.83%	-132.54%	-134.55%	-3744.17%	109.62%	54.83%	-933.33%

Earnings

Report Date	Jan 31, 2011	Apr 30, 2011	Jul 31, 2011	Oct 31, 2011	Jan 31, 2012	Apr 30, 2012	Jul 31, 2012	Oct 31, 2012	Jan 31, 2013	Apr 30, 2013	Jul 31, 2013	Oct 31, 2013	Jan 31, 2014	Apr 30, 2014	Jul 31, 2014	Oct 31, 2014	Mar 31, 2015	Jun 30, 2015	Sep 30, 2015	Dec 31, 2015	Mar 31, 2016	Jun 30, 2016	Sep 30, 2016	Dec 31, 2016	Mar 31, 2017	Jun 30, 2017	Sep 30, 2017	Dec 31, 2017	Mar 31, 2018	Jun 30, 2018	Sep 30, 2018	Dec 31, 2018	Mar 31, 2019	Jun 30, 2019	Sep 3, 2019	Dec 31, 2019	Mar 6, 2020	Jun 30, 2020	Sep 4, 2020	Dec 31, 2020	Mar 5, 2021	Jun 30, 2021	Sep 2, 2021	Mar 4, 2022	Sep 1, 2022	Mar 7, 2023	Mar 7, 2025	Sep 4, 2025
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EPS Actual	2.05	2.05	-1.20	-1.20	1.36	1.36	0.73	0.73	2.63	2.63	1.85	1.85	1.39	1.39	3.17	3.17	2.83	2.83	-0.68	-0.68	-0.58	-0.58	-0.39	-0.39	2.53	2.53	0.80	0.80	1.01	1.01	0.18	0.18	1.69	1.69	3.39	2.04	3.96	0.46	0.92	2.88	5.56	1.57	3.15	1.43	-4.62	2.52	-1.79	-0.28
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap581.46M

Enterprise Value582.01M

Trailing P/E5.54

Forward P/E0.00

PEG Ratio0.00

Price / Sales76.64

Price / Book1.01

EPS8.12

Book Value44.22

Revenue (TTM)7.59M

Gross Profit (TTM)7.59M

Profit Margin1371.16%

Operating Margin25.43%

Return on Equity19.27%

Return on Assets0.20%

Shares Outstanding12.92M

Shares Float0

Beta0.59

Dividend Yield6.99%

Dividend Rate3.15

Payout Ratio39.02%

Dividends

202612×

0.26Dec 11, 20260.26Nov 13, 20260.26Oct 15, 20260.26Sep 15, 20260.26Aug 14, 20260.26Jul 15, 20260.26Jun 15, 20260.26May 15, 20260.26Apr 15, 20260.26Mar 13, 20260.26Feb 13, 20260.26Jan 20, 2026

202512×

0.26Dec 22, 20250.26Nov 14, 20250.26Oct 15, 20250.26Sep 15, 20250.26Aug 15, 20250.26Jul 15, 20250.26Jun 13, 20250.26May 15, 20250.26Apr 15, 20250.26Mar 14, 20250.26Feb 14, 20250.26Jan 15, 2025